Taclonex

MC2 Therapeutics' psoriasis drug succeeds in Phase 3 trial
Biopharma Dive
Wed, 08/22/18 - 05:50 pm
MC2 Therapeutics
clinical trials
psoriasis
MC2-01
Taclonex